Title |
Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
|
---|---|
Published in |
Neurocritical Care, July 2018
|
DOI | 10.1007/s12028-018-0575-z |
Pubmed ID | |
Authors |
Daniel Hänggi, Nima Etminan, Stephan A. Mayer, E. Francois Aldrich, Michael N. Diringer, Erich Schmutzhard, Herbert J. Faleck, David Ng, Benjamin R. Saville, R. Loch Macdonald, for the NEWTON Investigators |
Mendeley readers
The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 73 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 19% |
Student > Master | 7 | 10% |
Student > Bachelor | 6 | 8% |
Professor | 5 | 7% |
Student > Doctoral Student | 4 | 5% |
Other | 15 | 21% |
Unknown | 22 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 26% |
Neuroscience | 9 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
Nursing and Health Professions | 3 | 4% |
Agricultural and Biological Sciences | 2 | 3% |
Other | 7 | 10% |
Unknown | 28 | 38% |